Abstract: The invention relates to a current-compensating device able to be connected, in shunt configuration, between an electrical network and non-linear and linear electrical loads and downstream of at least one renewable-energy-generating power unit coupled to an energy-storing element, the compensating device including: a power converting unit including at least one voltage inverter able to generate an AC current; an output filtering unit, including one filter dimensioned to block the harmonic components due to the switching of the inverter; a control unit comprising a unit for computing reference currents and a switch driving device that controls the switching of the inverter as a function of the identification of the currents by the unit for computing the reference currents.
Type:
Grant
Filed:
July 2, 2019
Date of Patent:
October 11, 2022
Assignees:
The University of Alabama in Huntsville
Abstract: [Problem] An adhesion-preventing material having a high adhesion-preventing effect has been demanded. [Solution] An adhesion-preventing material including a sterilized biocompatible sponge-like laminate, wherein the sponge-like laminate comprises a sponge-like first layer and a sponge-like second layer each of which is at least partially crosslinked with a curing agent and comprises a low-endotoxin alginic acid monovalent metal salt, the alginic acid monovalent metal salt in the first layer has a weight average molecular weight of 10,000 to 2,000,000, the alginic acid monovalent metal salt in the second layer has a weight average molecular weight of 1,000 to 1,000,000, the weight average molecular weights are measured by a GPC-MALS method after a decrosslinking treatment, and the weight average molecular weight of the alginic acid monovalent metal salt in the first layer is higher than that in the second layer.
Type:
Grant
Filed:
July 13, 2017
Date of Patent:
October 11, 2022
Assignees:
The University of Tokyo, Mochida Pharmaceutical Co., Ltd.
Abstract: To provide database generation techniques that can accurately and efficiently generate a database useable in text-based sound signal search. A sound signal database generation apparatus includes: a latent variable generation unit that generates, from a sound signal, a latent variable corresponding to the sound signal using a sound signal encoder; a data generation unit that generates a natural language representation corresponding to the sound signal from the latent variable and a condition concerning an index for a natural language representation using a natural language representation decoder; and a sound signal database generation unit that generates a record including the natural language representation corresponding to the sound signal and the sound signal from the natural language representation corresponding to the sound signal and the sound signal, and generates a sound signal database made up of the record.
Type:
Application
Filed:
April 8, 2020
Publication date:
October 6, 2022
Applicants:
NIPPON TELEGRAPH AND TELEPHONE CORPORATION, The University of Tokyo
Abstract: A carbon fiber reinforced composite material includes carbon fiber and a thermosetting resin composition. The thermosetting resin composition is a cured product of a liquid composition that contains unsaturated polyester, a curing agent, a polymerization initiator, and a nanocarbon/nanocellulose complex containing nanocarbon modified by functional a group and nanocellulose. The nanocarbon/nanocellulose complex is dispersed in the thermosetting resin composition. The thermosetting resin composition contains 0.05 to 15% by weight of the nanocarbon/nanocellulose complex. A maximum point stress of the carbon fiber reinforced composite material in a tensile test according to JIS K 7164 is 410 N/mm2 or more. A maximum point stress of the carbon fiber reinforced composite material in a three-point bending test according to JIS K 7171 is 310 N/mm2 or more.
Abstract: Provided herein are methods for identifying patient having treatment resistant cancers, such as HPV-related cancers. Therapeutic methods for treatment of cancers are also provided.
Type:
Application
Filed:
September 11, 2020
Publication date:
October 6, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: A method for controlling a wind turbine system connected to a power grid. The method comprises generating a wind turbine control signal based on a power control reference for controlling a power output of a wind turbine; monitoring an electrical frequency of the power grid; in response to detecting a change in the frequency in the power grid, activating a fast frequency support method comprising the steps of; adjusting the power control reference to cause an overproduction of power by the wind turbine; the overproduction of power causing a transfer of inertial kinetic energy from the wind turbine to electrical power; wherein the power control reference is determined by applying an adaptive gain function to a measurement of a difference in grid frequency from a nominal level.
Abstract: The present invention relates to compositions comprising exosomes and biological agents and methods of using the compositions for the delivery of biological agents to cells and to subjects.
Type:
Grant
Filed:
March 30, 2017
Date of Patent:
October 4, 2022
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Elena V. Batrakova, Alexander V. Kabanov, Marina Sokolsky, Matthew J. Haney, Dongfen Yuan, Myung Soo Kim
Abstract: Provided herein are methods of determining tumoral sensitivity to hormonal (endocrine) therapy based upon an index of estrogen receptor (ER)- and progesterone receptor (PR)-related genes, referred to as the sensitivity to endocrine therapy index (SETER/PR index), and may have additional consideration for the proportion of ER gene (ESRI) RNA transcripts that contain a mutation relative to the value of the SETER/PR index. Further provided are methods of treating breast cancer patients determined to be sensitive to an endocrine therapy by the SETER/PR index.
Type:
Grant
Filed:
April 28, 2017
Date of Patent:
October 4, 2022
Assignees:
Board of Regents, The University of Texas System, Yale University
Inventors:
William Fraser Symmans, Bruno Sinn, Christos Hatzis, Chunxiao Fu, Rosanna Lau
Abstract: Disclosed are functional materials for use in additive manufacturing (AM). The functional material can comprise an elastomeric composition (e.g., a silicone composite) for use in, for example, direct ink writing. The elastomeric composition can include and elastomeric resin, and a magnetic nanorod filler dispersed within the elastomeric resin. Nanorod characteristics (e.g., length, diameter, aspect ratio) can be selected to create 3D-printed constructs with desired mechanical properties along different axes. Furthermore, since nickel nanorods are ferromagnetic, the spatial distribution and orientation of nanorods within the continuous phase can be controlled with an external magnetic field. This level of control over the nanostructure of the material system offers another degree of freedom in the design of functional parts and components with anisotropic properties. Magnetic fields can be used to remotely sense compression of the constructs, or alternatively, control the stiffness of these materials.
Type:
Grant
Filed:
June 8, 2020
Date of Patent:
October 4, 2022
Assignee:
The University of Kansas
Inventors:
Cory Berkland, Jonathan Whitlow, Jean Salash
Abstract: Provided herein are compositions comprising: (a) a polymeric catechol binder, such as: polymeric dopamine, polymeric norepinephrine, polymeric epinephrine; polymeric pyrogallol, polymeric tannic acid, polymeric hydroxyhydroquinone, polymeric catechin, polymeric epigallocatechin etc.; and (b) a hydrophilic polymer, methods for using the compositions to coat a substrate, and methods for making the compositions. In particular, the substrate may form part of an apparatus on which it would be beneficial to limit biofouling and/or protein binding.
Type:
Grant
Filed:
May 26, 2016
Date of Patent:
October 4, 2022
Assignee:
The University of British Columbia
Inventors:
Jayachandran N. Kizhakkedathu, Dirk Lange, Joey Lo, Yan Mei, Kai Yu
Abstract: Aspects of the disclosure relate to compositions of enzyme-binding polypeptides (EBPs) that modify the substrate specificity of an enzyme and a method for identifying an EBP that modifies substrate specificity of an enzyme binding at least one substrate, the method comprising: contacting the enzyme with a polypeptide library comprising a plurality of EBPs that bind different epitopes of the enzyme; identifying EBPs that bind to the enzyme to form an EBP-enzyme complex; assaying for the activity level and substrate specificity of the EBP-enzyme complex; and identifying EBPs that modify the substrate specificity of the enzyme by identifying EBPs that, when in an EBP-enzyme complex, have a different substrate specificity than un-complexed EBP; wherein the catalytic rate constant of the EBP-enzyme complex is ?50% of the un-complexed enzyme for at least one substrate and/or wherein the EBP-enzyme complex retains binding to a substrate.
Abstract: Systems, methods, and computer-readable storage media facilitating automated testing of datasets including natural language data are disclosed. In the disclosed embodiments, rule sets may be used to condition and transform an input dataset into a format that is suitable for use with one or more artificial intelligence processes configured to extract parameters and classification information from the input dataset. The parameters and classes derived by the artificial intelligence processes may then be used to automatically generate various testing tools (e.g., scripts, test conditions, etc.) that may be executed against a test dataset, such as program code or other types of data.
Type:
Grant
Filed:
March 20, 2020
Date of Patent:
October 4, 2022
Assignees:
The University of Chicago, President and Fellows of Harvard College, Yale University
Inventors:
Dacheng Xiu, Zheng Tracy Ke, Bryan Kelly
Abstract: The present invention relates to compositions and adeno associated viral vectors comprising an optimised HGSNAT nucleic acid sequence of SEQ ID No. 1 or a derivative sequence having at least 77% homology thereof. Uses of such compositions and vectors are also contemplated along with kits of parts for their administration.
Type:
Grant
Filed:
July 12, 2017
Date of Patent:
October 4, 2022
Assignees:
The University of Manchester, Centre Hospitalier Universitaire Sainte-Justine
Inventors:
Alexey Pchejetsky, Brian Bigger, Claire O'Leary
Abstract: Provided herein are methods for identifying and treating cancers that are resistant to PARP inhibition. Methods for sensitizing cancers to a PARP inhibitor therapy are also provided. In some aspects, PARP inhibitor cancers are treated with a PARP inhibitor therapy in combination with a receptor tyrosine kinase inhibitor.
Type:
Application
Filed:
June 10, 2020
Publication date:
September 29, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: The present invention provides a mutant FAD-dependent glucose dehydrogenase comprising: a catalytic subunit; an electron transfer subunit; and a hitchhiker subunit; wherein each of the amino acid sequence of the catalytic subunit and the amino acid sequence of the electron transfer subunit comprises a cysteine residue introduced therein, the catalytic subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues to achieve improved thermal stability of the FAD-dependent glucose dehydrogenase.
Type:
Application
Filed:
October 21, 2021
Publication date:
September 29, 2022
Applicants:
The University of North Carolina at Chapel Hill, ARKRAY, Inc.
Inventors:
Koji Sode, Junko Shimazaki, Katsuhiro Kojima, Masashi Tsukada
Abstract: In an embodiment, the present disclosure pertains to a composition. In some embodiments, the composition includes a cross-linked network of cyclic macromolecules. In some embodiments, the cyclic macromolecules are covalently cross-linked to one another by a plurality of cross-linking agents. In some embodiments, at least some of the cross-linking agents are covalently functionalized with a plurality of functional groups. In some embodiments, the plurality of functional groups include a chain of at least three atoms that protrude out of the cross-linking agents. In some embodiments, the cross-linking agents and the functional groups form a polymer matrix, such as poly (?-amino ester). In some embodiments, the composition is in the form of particles. In another embodiment, the present disclosure pertains to a method of administering an active agent to a subject. In some embodiments, the method includes administering a composition of the present disclosure to the subject.
Type:
Application
Filed:
March 25, 2020
Publication date:
September 29, 2022
Applicant:
Board of Regents of The University of Texas System
Abstract: Here, the inventors describe methods and compositions for targeting a TLR agonist to the tumor cell or stroma. Aspects of the disclosure relate to a polypeptide comprising a tumor targeting agent operatively linked to p(Man-TLR). Also disclosed are compositions and methods for treating cancer in a subject comprising administration of the polypeptide comprising the tumor targeting agent linked to p(Man-TLR) to the subject.
Type:
Application
Filed:
June 3, 2020
Publication date:
September 29, 2022
Applicant:
The University of Chicago
Inventors:
Jeffrey A. HUBBELL, David S. WILSON, Tiffany M. MARCHELL, Laura T. GRAY
Abstract: This invention provides biomarkers (e.g., methylation of R198 or R200 of EGFR or the presence of an arginine at position 497 of EGFR) for the prediction of resistance to cetuximab therapy. This invention also provides methods for the selection of patients for combination therapy with cetuximab and PRMT inhibitors.
Type:
Grant
Filed:
December 4, 2019
Date of Patent:
September 27, 2022
Assignee:
Board of Regents, The University of Texas System
Abstract: Effective techniques for patterning carbon nanotube (CNT) sheets are disclosed herein. A carbon nanotube forest is grown on a catalyst-incorporated substrate, CNT sheets are drawn from the carbon nanotube forest, the CNT sheets are stacked on a substrate, followed by etching the CNT sheets by using a shadow mask through a controlled etch process. In some implementations, etching of the CNT sheets is carried out in a capacitively coupled plasma (CCP) etching system, where the CNT sheets are selectively exposed, in a controlled environment, to oxygen plasma via the shadow mask.
Type:
Grant
Filed:
October 21, 2019
Date of Patent:
September 27, 2022
Assignee:
Board of Regents, The University of Texas System
Inventors:
Behnoush Dousti, Gil Sik Lee, Negar Geramifard